- Recent Funding
- Investors
- LimmaTech Biologics
LimmaTech Biologics portfolio
LimmaTech Biologics has 1 portfolio company on record at Recent Funding. Its most recent investment on record is GlycoEra's $49M Series A round in November 2021, alongside Sofinnova Partners, Roche Venture Fund and 5AM Ventures. That company is in Health and bio.
What LimmaTech Biologics invests in
- Health and bio · 1 · 100%
How LimmaTech Biologics invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $49M |
Share is of the 1 round on Recent Funding that name LimmaTech Biologics. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
LimmaTech Biologics portfolio companies
| Company | Round with LimmaTech Biologics | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $49M | $179M | May 27, 2025 Series B+ |
Most frequent co-investors
SSofinnova Partners1 shared round · last Nov 5, 2021
RRoche Venture Fund1 shared round · last Nov 5, 2021
55AM Ventures1 shared round · last Nov 5, 2021
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
AAngel Academe1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moDDeepWork Capital1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists LimmaTech Biologics, which is a subset of its real portfolio. API: /api/v1/investors/limmatech-biologics (get a free API key). More: the most active VC firms and new venture capital funds.